Filters: author is Danhof [Clear All Filters]
- 1981
Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation,
Pharmacology, vol. 22, no. 6, pp. 349-58.
- 1980
Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery,
Br J Clin Pharmacol, vol. 10, no. 4, pp. 363-8.
Studies on the different metabolic pathways of antipyrine as a tool in the assessment of the activity of different drug metabolizing enzyme systems in man [proceedings],
Br J Pharmacol, vol. 68, no. 1, pp. 121P.
- 1979
Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment,
Xenobiotica, vol. 9, no. 11, pp. 695-702.
Influence of bile salts on hepatic transport of dibromosulphthalein,
Am J Physiol, vol. 237, no. 6, pp. E524-34.
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers,
Br J Clin Pharmacol, vol. 8, no. 6, pp. 529-37.
Assay of 3-carboxy-antipyrine in urine by capillary gas chromatography with nitrogen selective detection. Some preliminary results in man,
Pharmacology, vol. 19, no. 4, pp. 215-20.
Assay of antipyrine and its primary metabolites in plasma, saliva and urine by high-performance liquid chromatography and some preliminary results in man,
Pharmacology, vol. 18, no. 4, pp. 210-23.
- 1978
Therapeutic drug monitoring in saliva,
Clin Pharmacokinet, vol. 3, no. 1, pp. 39-57.
